FungiScope study for confirmed invasive fungal infections
Part of Infections clinical trials.
This study enrolls people who have test results showing an invasive fungal infection (a fungus causing illness inside the body). The goal is to build a global registry to better understand these infections and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have evidence from tests like culture, tissue exam, antigen testing, or DNA testing that shows invasive fungal infection
- Your infection must not be due to Candida species
- Your infection must not be due to Cryptococcus neoformans
- Your infection must not be due to Pneumocystis jirovecii
- Your infection must not be an “endemic” fungus like coccidioidomycosis or histoplasmosis, and it must be invasive (not just colonization or a non-invasive infection)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to find infections (using a test called mNGS) that may be quicker and more accurate than standard tests. It is for people with blood cancers who show signs of a possible fungal infection, like fever or abnormal lung scans.
This trial studies two types of antifungal medicines (amphotericin B and azoles) to see which works better for people with invasive fungal disease. It aims to help doctors choose the safest and most effective treatment.
This study tracks how your immune system responds to serious mold infections, like aspergillosis or mucormycosis. It may help doctors understand why some infections are hard to treat and could lead to better care.
This study is a hospital registry that collects health and test information about people with confirmed invasive Candida (a fungal infection). It may help doctors understand who gets these infections and how they spread, which can improve future diagnosis and care.
This study is testing a new blood or fluid test that may find drug-resistant fungus in people with a weakened immune system who have a serious lung infection. The results could help doctors choose the right medicine faster.
This trial looks at lab test results from samples taken to check for a serious (invasive) fungal infection caused by fusarium. It may help improve how doctors identify the infection and its drug resistance, which can guide better treatment.
Hear when a new Invasive Fungal Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.